Ittai Harel

Ittai Harel is a Director at Homethrive and has over 16 years of experience as an investor in Digital Health, Medical Devices, Diagnostics, and Therapeutic development companies. Ittai advises and assists entrepreneurs and management in the development of their companies. Ittai is also a Director Board of Directors for Connie Health, ImmuneID, and Homethrive, Inc. In addition, they are an Observer for Visby Medical and a Director Board of Directors for TScan Therapeutics. Ittai has been a Member of the Board of Directors for CLEW for 5 years 6 months and an Investment Committee for MindUP - The Digitial Health Incubator for 6 years 6 months. Moreover, they are a Director Board of Directors for Medisafe Medication Adherence Platform and Vertos Medical Inc. Furthermore, they are the Chairman of the Board of Directors for EarlySense and LifeBond Ltd. Lastly, they are a Member of the Board of Directors for Inotek Pharmaceuticals and Valeritas. Prior to their current position, they were Corporate Development for Nektar Therapeutics and Exec VP, Corporate Development for IDGene Pharmaceuticals.

Ittai Harel has an MSc from the MIT Sloan School of Management, where they studied management and marketing. Ittai also has a BSc from Ben-Gurion University of the Negev, where they studied chemical engineering and biotechnology.

Ittai Harel, Director, works with the Israel team.